Experimental and clinical evidence have indicated that the CXCL12/CXCR4 axis promotes new blood vessel formation in diverse types of malignancies, including breast, ovarian, prostate, hepatic, gastric, colorectal cancer, and glioma [57,58,59,60,61,62,166]. This evidence concerns the gene CXCL12 and central nervous system cancer.